MENU
IBRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ImmunityBio (IBRX) Ownership - Who owns ImmunityBio?
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
3530 John Hopkins Court
Phone
+1 844 696-5235
Employees
628
Web
https://www.immunitybio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.52B
P/E Ratio
N/A
Total Cash
61.59M
Projected Growth
N/A
Total Debt
526.27M
Revenue
31.22M
Risk (Beta)
-0.16
Dividend Yield
N/A
Total Cash/Share
0.07
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
IBRX
Capitalization
2.52B
P/E Ratio
N/A
Risk (Beta)
-0.16
Dividend Yield
N/A
Total Cash
61.6M
Total Cash/Share
0.07
Total Debt
526M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
31.2M
ROE
N/A
Book Value
-591.43M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.54
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
85K
Current Ratio
2.22
Current Revenue Per Employee
24615.50
Dividends Per Share - Security
N/A
EBITDA
-264M
Float
N/A
Float - Current
N/A
Gross Income Margin
99.65
Revenue To Assets
-116.15
Shares Held By Institutions
386M
Shares Outstanding - Current
883M
Total Liabilities
894M
Total Volume MTD
N/A
Value
1
Gain YTD
11.719
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a producer of cancer treatment products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
3530 John Hopkins Court
Phone
+1 844 696-5235
Employees
628
Web
https://www.immunitybio.com